FDASanyou Biopharmaceuticals Laboratory Animal Ethics Committeemirvetuximab soravtansinegemcitabineexatecanplatinum-resistant ovarian cancerrecurrent diseaseepithelial ovarian cancersClone 65SKOV3
…tant setting, where treatment options remain limited. While the FDA has approved mirvetuximab soravtansine for platinum-resistant o…